Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_assertion type Assertion NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_head.
- NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_assertion wasGeneratedBy ECO_0000203 NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_provenance.
- NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_assertion wasDerivedFrom befree-20140225 NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_provenance.
- NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_assertion SIO_000772 23547049 NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_provenance.
- NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_assertion evidence source_evidence_literature NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_provenance.
- NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_assertion description "[Deletion of CD44 during TCL1-driven murine leukemogenesis reduced the tumor burden in peripheral blood and spleen and led to a prolonged overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451853.RA21-NPn89BRsDm5mN_vEwPyvVJO8Qfn5vu5w4iGEJNGI130_provenance.